Today on DrugResearcher.com   Johnson & Johnson slashes jobs, closes facilities Gene therapy skies grey again Teaching computers to read chemical structures Tepnel to launch new molecular services Drugs moving into the clinic: 23

Related Industry News   India one step closer to amending Phase I rules GPC Biotech withdraws satraplatin NDA Rexam O-I purchase complete amid muted H1 results Amgen Q2 not 'up to scratch'

Breaking News on Drug Discovery
Daily  Wednesday 01 August 2007		Forward to a colleague

	Sponsored Message Live cell-based assay with Bionas® 2500 analyzing system Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here Access Full Stories Johnson & Johnson slashes jobs, closes facilities Johnson & Johnson (J&J) has become the latest big pharma player to cut jobs and close facilities, in another example of the changing face of the industry landscape... Read Gene therapy skies grey again Just as the biopharma industry was recovering from its hangover after negative clinical events in the gene therapy field, the death of a patient during a gene therapy trial last week puts a cloud in the sky for... Read Teaching computers to read chemical structures German scientists have developed software that can recognise chemical structure images and convert them into a computer readable format to enable graphical searching of patents and scientific papers... Read Tepnel to launch new molecular services Tepnel Research Products & Services has indicated it will soon begin offering a number of new molecular services at its new facility in Livingston, Scotland... Read Drugs moving into the clinic: 23 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: August | July | June
	Product Overview A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
	Related Industry News India one step closer to amending Phase I rules India could be a step closer to allowing first-in-man trials on 'foreign' new drugs... Read GPC Biotech withdraws satraplatin NDA GPC Biotech has withdrawn its hotly touted satraplatin New Drug Application (NDA) for accelerated approval following last week's less than glowing recommendation to hold off on its approval... Read Rexam O-I purchase complete amid muted H1 results UK packaging firm Rexam has today announced the completion of its acquisition of the plastic packaging arm of US company O-I, shortly after releasing somewhat lacklustre results for the first half of the financial... Read Amgen Q2 not 'up to scratch' Amgen has posted stumpy financial results for the second quarter of the year mainly due to the poor performance of its anaemia drug Aranesp... Read Weekly comment UK ordered to review animal testing approval system The UK government has been ordered to review the assessment system it uses to classify and grant permission for animal experiments following a court ruling handed down last week. Read Sponsored Message Discover our New Alert Service DrugResearcher has launched a New Alert service on product and market innovation. To indicate your research interests and to subscribe to our FREE alerts,... Click Here Previous Headlines Nikon to care for your cells while you study them Nikon have launched a new 'hands off' system that combines an incubator and inverted microscope to allow automated live-cell culture studies and time-lapse imaging in a controlled environment... Read Medivation drug sets its sights on Huntington's disease Having already shown promising results in Alzheimer's patients, Medivation's drug that protects brain cells is now entering mid-stage clinical trials for Huntington's disease... Read Novogen's arthritis drug edges towards human trials The latest preclinical experiments by Novogen on its new class of arthritis drugs have encouraged the Australian biotech company in its quest to test the new treatment concept in clinical trials... Read BioWa antibodies 'the ultimate warriors' to fight cancer US-based biopharma company BioWa has found a way of increasing an antibody's ability to initiate the complement immune system and blow holes in tumour cells... Read Xceleron grabs a piece of American pie UK-based microdosing specialist Xceleron has announced its expansion with the takeover of a new facility in the US, two years after setting up a business base in the region... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com